Literature DB >> 31451280

Prevalence of dysphagia in a regional hospital setting: Acute care hospital and a geriatric sociosanitary care hospital: A cross-sectional study.

Amaya Peñalva-Arigita1, Rosa Prats2, Maria Lecha2, Anna Sansano2, Lluis Vila3.   

Abstract

RATIONALE: Oropharyngeal Dysphagia (OD) is a symptom commonly found in hospitalized patients and related to a vast array of clinical diagnosis and to high morbidity and mortality that is becoming very important to identify. Our aim was to assess the prevalence of OD in our hospital setting.
METHODS: Cross-sectional randomized study to determine the prevalence of dysphagia in an acute care hospital (ACH) and long term care hospital (LTCH). Multiquestionnaire test performed to assess dysphagia with the bedside validated volume-viscosity swallow test (V-VST test), in those with the validated swallowing ability test, eating assessment tool (EAT-10)>3. Variables; sex, age (>65 y), diagnosis, mininutritional assessment (MNA), previous diagnosis of dysphagia (including any recommendations given before), EAT-10, V-VST, presence of dysphagia, type of diet prescribed (basal or therapeutic), use of thickener and diet texture (pureed with liquids allowed, pureed without liquids, soft diet, normal).
RESULTS: N = 200 patients (100 in each centre). 49% male; Age = 81.1 [65-101] years; Diagnostics: medical 70%/surgery 30%. Dysphagia analysis: 42% patients showed an EAT-10 > 3 so the V-VST test was done in these patients resulting in global prevalence of 28.5% (95% CI: 22.7-35.1). Among centres no significant differences were observed: ACH 30% (95% CI: 14-34) and LTCH 27% (95% CI: 19-36). Highlighting a greater concentration of dysphagia in Orthogeriatric and Neurological patients in the LTCH than in ACH (Pneumology, Internal Medicine and Cardiology). MNA analysis: 27% normal 44% risk 29% malnutrition. Malnutrition present in 50.9% of patients diagnosed with dysphagia, 44% in those at risc (EAT-10 +) and 27.6% in those without risc or dysphagia (p = 0.020). From the novo patients, 75.4% did not have adequate complete adapted treatment (diet and thickener). Only 13.3% had their thickener prescribed. In those with history of dysphagia 37% had an inappropriate treatment.
CONCLUSION: Prevalence of OD matches with what is described in the literature. There is a high proportion of infradiagnostic and overall inadequate treatment, more than a third of patients do not have their diet adapted correctly. It is important to identify this symptom to treat it properly and to raise awareness among sanitary professionals for best adaptation of treatment.
Copyright © 2019 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Dysphagia; Malnutrition; Prevalence; Sociosanitary

Year:  2019        PMID: 31451280     DOI: 10.1016/j.clnesp.2019.07.003

Source DB:  PubMed          Journal:  Clin Nutr ESPEN        ISSN: 2405-4577


  2 in total

1.  Best Practice Recommendations for Geriatric Dysphagia Management with 5 Ws and 1H.

Authors:  Ebru Umay; Sibel Eyigor; Gulistan Bahat; Meltem Halil; Esra Giray; Pelin Unsal; Zeliha Unlu; Canan Tikiz; Meltem Vural; Asli Tufan Cincin; Serkan Bengisu; Eda Gurcay; Kemal Keseroglu; Banu Aydeniz; Elif Celik Karaca; Burak Karaca; Ahmet Yalcin; Cemile Ozsurekci; Dilek Seyidoglu; Ozlem Yilmaz; Sibel Alicura; Serhat Tokgoz; Barin Selcuk; Ekin Ilke Sen; Ali Yavuz Karahan; Ayse Yaliman; Serdar Ozkok; Birkan Ilhan; Merve Guner Oytun; Zeynel Abidin Ozturk; Sibel Akin; Betul Yavuz; Mazlum Serdar Akaltun; Aylin Sari; Murat Inanir; Meral Bilgilisoy; Zuhal Çaliskan; Guleser Saylam; Tugce Ozer; Yasemin Eren; Derya Hopanci Bicakli; Dilek Keskin; Zekeriya Ulger; Aylin Demirhan; Yalkin Calik; Bulent Saka; Zeynep Aykin Yigman; Erhan Arif Ozturk
Journal:  Ann Geriatr Med Res       Date:  2022-05-09

Review 2.  Texture-Modified Diets, Nutritional Status and Mealtime Satisfaction: A Systematic Review.

Authors:  Xiaojing Sharon Wu; Anna Miles; Andrea J Braakhuis
Journal:  Healthcare (Basel)       Date:  2021-05-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.